Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor

Genes Chromosomes and Cancer

Volumn 49, Issue 2, 2010, Pages 176-181

  Kordes, Uwe ^a   Gesk, Stefan ^b   Frühwald, Michael Christoph ^c   Graf, Norbert ^d   Leuschner, Ivo ^b   Hasselblatt, Martin ^c   Jeibmann, Astrid ^c   Oyen, Florian ^a   Peters, Ove ^e   Pietsch, Torsten ^f   Siebert, Reiner ^b   Schneppenheim, Reinhard ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CHROMOSOME BREAKAGE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CLUSTER; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MISSENSE MUTATION; ONCOGENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHABDOID TUMOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMARCB1 GENE; TERATOMA;

CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; EXONS; FAMILY; FEMALE; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKOCYTES; MALE; MUTATION; POLYMERASE CHAIN REACTION; RHABDOID TUMOR; SEQUENCE DELETION; TRANSCRIPTION FACTORS;

EID: 75149150033     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20729     Document Type: Article

References (24)

1. Ammerlaan ACJ, Ararou A, Houben MPWA, Baas F, Tijssen CC, Teepen JLJM, Wesseling P, Hulsebos TJM. 2008. Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome. Br J Cancer 98:474-479.
2. Biegel JA. 2006. Molecular genetics of atypical teratoid/rhabdoid tumor. Neurosurg Focus 20:E11.
3. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. 2002. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8:3461-3467.
4. Boyd C, Smith M, Kluwe L, Balogh A, Maccollin M, Plotkin S. 2008. Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet 74:358-366.
5. Chi S, Fletcher W, Yao X, Cohen K, Fisher M, Biegel J, Janss A, Goldman S, Bowers D, Manley P, Masewski C, Bendel A, Rubin J, Turner CD, Roberts C, Marcus K, Goumnerova L, Ullrich N, Chordas C, Zimmerman MA, Kieran MW. 2008. ATRT 12. Results from a single-arm, multiinstitutional phase II study of multiagentintrathecal and systemic chemotherapy with age- and risk-adapted radiation therapy for children with newly diagnosed CNS atypical teratoid/rhabdoid tumor (DFCI 02-294). Neuro-Oncology 10:373.
6. Frühwald MC, Hasselblatt M, Wirth S, Köhler G, Schneppenheim R, Subero JIM, Siebert R, Kordes U, Jürgens H, Vormoor J. 2006. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome. Pediatr Blood Cancer 47:273-278.
7. Gardner SL, Asgharzadeh S, Green A, Horn B, McCowage G, Finlay J. 2008. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatr Blood Cancer 51:235-240.
8. Haberler C, Laggner U, Slavc I, Czech T, Ambros IM, Ambros PF, Budka H, Hainfellner JA. 2006. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Am J Surg Pathol 30:1462-1468.
9. Hadfield KD, Newman WG, Bowers NL, Wallace A, Bolger C, Colley A, McCann E, Trump D, Prescott T, Evans DGR. 2008. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J Med Genet 45:332-339.
10. Jackson E, Shaikh T, Gururangan S, Jones M, Malkin D, Nikkel S, Zuppan C, Wainwright L, Zhang F, Biegel J. 2007. Highdensity single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor. Hum Genet 122:117-127.
11. Janson K, Nedzi LA, David O, Schorin M, Walsh JW, Bhattacharjee M, Pridjian G, Tan L, Judkins AR, Biegel JA. 2006. Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation. Pediatr Blood Cancer 47:279-284.
12. Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA. 2004. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28:644-650.
13. McKenna ES, Sansam CG, Cho YJ, Greulich H, Evans JA, Thom CS, Moreau LA, Biegel JA, Pomeroy SL, Roberts CWM. 2008. Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. Mol Cell Biol 28:6223-6233.
14. Perry A, Fuller CE, Judkins AR, Dehner LP, Biegel JA. 2005. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol 18:951-958.
15. Roberts CW, Orkin SH. 2004. The SWI/SNF complex-chromatin and cancer. Nat Rev Cancer 4:133-142.
16. Savla J, Chen TT, Schneider NR, Timmons CF, Delattre O, Tomlinson GE. 2000. Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors. J Natl Cancer Inst 92:648-650.
17. Sestini R, Bacci C, Provenzano A, Genuardi M, Papi L. 2008. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. Hum Mutat 29:227-231.
18. Sevenet N, Lellouch-Tubiana A, Schofield D, Hoang-Xuan K, Gessler M, Birnbaum D, Jeanpierre C, Jouvet A, Delattre O. 1999a. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet 8:2359-2368.
19. Sevenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O. 1999b. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 65:1342-1348.
20. Swensen JJ, Keyser J, Coffin CM, Biegel JA, Viskochil DH, Williams MS. 2009. Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1. J Med Genet 46:68-72.
21. Taylor MD, Gokgoz N, Andrulis IL, Mainprize TG, Drake JM, Rutka JT. 2000. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. Am J Hum Genet 66:1403-1406.
22. Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, Krasin M, Dalton J, Hale G, Kun LE, Wallace D, Gilbertson RJ, Gajjar A. 2005. Atypical teratoid/rhabdoid tumors (ATRT): Improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 23:1491-1499.
23. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. 1998. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203-206.
24. Zhang F, Tan L, Wainwright LM, Bartolomei MS, and Biegel JA, . 2002. No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors. Genes Chromosomes Cancer 34:398-405.